Skip to main content

Here's the latest on UPMC's development of small antibody to fight SARS-CoV-2

The work for Ab8 began as a direct result of UPMC's increased emphasis several years ago in translational science, immunotherapy and the recruitment of a global antibody expert.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.